Optimal Treatment of Vascular Birthmarks

American Journal of Clinical Dermatology

Volumn 4, Issue 11, 2003, Pages 745-756

  Werner, Jochen A ^a   Dünne, Anja A ^a   Lippert, Burkard M ^a   Folz, Benedikt J ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISONE; SCLEROSING AGENT;

ANGIOOSTEOHYPERTROPHY SYNDROME; APPETITE DISORDER; ARTIFICIAL EMBOLISM; BEHAVIOR DISORDER; BODY POSTURE; BONE MARROW SUPPRESSION; CLINICAL FEATURE; CONGENITAL BLOOD VESSEL MALFORMATION; CRYING; CRYOTHERAPY; CUSHINGOID SYNDROME; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; FATIGUE; FEVER; GAIT DISORDER; GASTROESOPHAGEAL REFLUX; GLUCOSURIA; GROWTH RETARDATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOPIGMENTATION; IMMUNOSUPPRESSIVE TREATMENT; IRRITABILITY; KIDNEY FAILURE; LOW LEVEL LASER THERAPY; MALAISE; NAUSEA; NEODYMIUM LASER; NEUROLOGIC DISEASE; NEVUS FLAMMEUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SCLEROTHERAPY; SIDE EFFECT; SKIN ATROPHY; SKIN HEMANGIOMA; SPASTICITY; SPEECH DISORDER; STURGE WEBER SYNDROME; TREATMENT OUTCOME; ULCER; ULTRASOUND;

ARTERIOVENOUS MALFORMATIONS; HEMANGIOMA; HUMANS; PORT-WINE STAIN; SKIN NEOPLASMS;

EID: 0344011554     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200304110-00003     Document Type: Review

References (67)

1. Garzon MC, Enjolras O, Frieden IJ. Vascular tumors and vascular malformations: evidence for an association. J Am Acad Dermatol 2000; 42: 275-9
2. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations of infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69: 412-22
3. Hand JL, Frieden IJ. Vascular birthmarks of infancy: resolving nosologic confusion. Am J Med Genet 2002; 108: 257-64
4. North PE, Waner M, Mizeracki A, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001; 137: 559-70
5. North PE, Waner M, Mizeracki A, et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000; 31: 11-22
6. Walter JW, North PE, Waner M, et al. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes Cancer 2002; 33: 295-303
7. Bowers RE, Graham EA, Tomlinson KM. The natural history of strawberry nevus [letter]. Arch Dermatol 1960; 82: 667
8. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 1983; 18: 894-900
9. Fishman SJ, Mulliken JB. Hemangiomas and vascular malformations of infancy and childhood. Pediatr Clin North Am 1993; 40: 1177-200
10. Rogers M, Lam A, Fischer G. Sonographic findings in a series of rapidly involuting congenital hemangiomas (RICH). Pediatr Dermatol 2002; 19: 5-11
11. Waner M, Suen JY, editors. Hemangiomas and vascular malformations of the head and neck. New York: Wiley-Liss, 1999
12. Mallucci P. Vascular anomalies must be properly classified [letter]. BMJ 2000; 2: 919
13. Low DW. Hemangiomas and vascular malformations. Semin Pediatr Surg 1994; 3: 40-61
14. Eichenfield LF. Evolving knowledge of hemangiomas and vascular malformations. Arch Dermatol 1998; 134: 740-2
15. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol 1998; 13: 375-422
16. Powell J. Update on hemangiomas and vascular malformations. Dermatology 1999; 11: 457-63
17. Takahashi K, Mulliken JB, Kozakewich HP, et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994; 93: 2357-64
18. Dosquet C, Coudert MC, Wassel M, et al. Interet du dosage du bFGF ('basic fibroblast growth factor') pour le diagnostic et le traitement des hemangiomes. Ann Dermatol Venereol 1998; 125: 313-6
19. Mulliken JB. Cutaneous vascular anomalies. Semin Vasc Surg 1993; 6: 204-18
20. ApSimon HT, Reef H, Phadke RV, et al. A population-based study of brain arteriovenous malformation: long-term treatment outcomes. Stroke 2002; 33: 2794-800
21. Zorzan G, Tullio A, Baj A, et al. Arteriovenous malformations of the head and neck: diagnosis and methods of treatment. Minerva Stomatol 2001; 50: 351-9
22. Donald PJ. Vascular anomalies of the head and neck. Facial Plast Surg Clin North Am 2001; 9: 77-92
23. Calonje E, Wilson-Jones E. Vascular tumors: tumors and tumor-like conditions of blood vessels and lymphatics. In: Elder D, Elenitsas R, Jaworsky C, et al., editors. Lever's histopathology of the skin. 8th ed. Philadelphia: Lipincott, 1997: 899
24. Esterly NB. Cutaneous hemangiomas, vascular stains, and associated syndromes. Curr Probl Pediatr 1987; 17: 1-69
25. Lindenauer SM. Klippel-Trenaunay syndrome [letter]. Ann Surg 1965; 162: 303
26. Cohen SR, Thompson JW. Lymphangiomas of the larynx in infants and children: a survey of pediatric lymphangioma. Ann Otol Rhinol Laryngol Suppl 1986; 127: 1-20
27. Emery PJ, Bailey CM, Evans JN. Cystic hygroma of the head and neck: a review of 37 cases. J Laryngol Otol 1984; 98: 613-9
28. Brown SH, Neerhout RC, Fonkalsrud EW. Prednisone therapy in management of large hemangiomas in infants and children. Surgery 1972; 71: 168-73
29. Burrows PE, Lasjaunias PL, Ter Brugge KG, et al. Urgent and emergent embolization of lesions of the head and neck in children: indications and results. Pediatrics 1987; 80: 386-94
30. Waner M, Suen JY. Treatment of hemangiomas of the head and neck. Laryngoscope 1992; 102: 1123-32
31. Werner JA, Lippert BM, Gottschlich S, et al. Ultrasound-guided interstitial Nd: YAG laser treatment of voluminous hemangiomas and vascular malformations in 92 patients. Laryngoscope 1998; 108: 463-70
32. Bassukas ID, Abuzahra F, Hundeiker M. Regression phase as therapeutic goal of cryosurgical treatment of growing capillary infantile hemangiomas: treatment decision, treatment strategy and results of an open clinical study. Hautarzt 2000; 51: 231-8
33. Reischle S, Schuller-Petrovic S. Treatment of capillary hemangiomas of early childhood with a new method of cryosurgery. Am Acad Dermatol 2000; 42: 809-13
34. Michel S, Wlotzke U, Hohenleutner U, et al. Laser and cryotherapy of hemangioma in infants in a direct comparison. Hautarzt 1998; 49: 192-6
35. Noppen M, Meysman M, Van Herreweghe R, et al. Bronchoscopic cryotherapy: preliminary experience. Acta Clin Belg 2001; 56: 73-7
36. Enjolras O, Riche MC, Merland JJ, et al. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 1990; 85: 491-8
37. Uysal KM, Olgun N, Erbay A, et al. High-dose oral methylprednisolone therapy in childhood hemangiomas. Pediatr Hematol Oncol 2001; 18: 335-41
38. Edgerton MT. The treatment of hemangiomas: with special reference to the role of steroid therapy. Ann Surg 1976; 183: 517-32
39. Cohen SR, Wang CI. Steroid treatment of hemangioma of the head and neck in children. Ann Otol Rhinol Laryngol 1972; 81: 584-90
40. Sadan N, Wolach B. High dose oral prednisone for hemangiomas in infants. Harefuah 1997; 132: 684-91, 744
41. Baumann NM, Burke DK, Smith RJH. Treatment of massive or life-threatening hemangiomas with recombinant alfa-2a interferon. Otolaryngol Head Neck Surg 1997; 117: 99-110
42. Greinwald JH, Burke DK, Bonthius DJ, et al. An update on the treatment of hemangiomas in children with interferon alfa-2a. Arch Otolaryngol Head Neck Surg 1999; 125: 21-7
43. Fledelius HC, Illum N, Jensen H, et al. Interferon-alfa treatment of facial infantile haemangiomas: with emphasis on the sight-threatening varieties: a clinical series. Acta Ophthalmol Scand 2001; 79: 370-3
44. Cirelli R, Tyring SK. Major therapeutic uses of interferons. Clin Immunother 1995; 3: 27-87
45. Jonas GJ, Itri LM. Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients. Cancer 1986; 57: 1709-15
46. Worle H, Maass E, Kohler B, et al. Interferon alpha-2a therapy in haemangiomas of infancy: spastic diplegia as a severe complication. Eur J Pediatr 1999; 158: 344
47. Werner JA, Lippert BM, Geisthoff UW, et al. Nd: YAG Lasertherapie der rezidivierenden Epistaxis bei hereditärer hämorrhagischer Teleangiektasie. Laryngorhinootologie 1997; 76: 495-501
48. Werner JA, Lippert BM, Hoffmann P, et al. Nd: YAG laser therapy of voluminous hemangiomas and vascular malformations. Adv Otorhinolaryngol 1995; 49: 75-80
49. Werner JA, Lippert BM, Godbersen GS, et al. Die Hämangiombehandlung mit dem Neodym:Yttrium-Aluminum-Granat Laser (Nd: YAG-Laser). Laryngorhinootologie 1992; 71: 388-95
50. Werner JA, Rudert H. Der Einsatz des Nd: YAG Lasers in der Hals-, Nasen, Ohrenheilkunde. HNO 1992; 40: 248-58
51. Gupta G, Bilsland D. A prospective study of the impact of laser treatment on vascular lesions. Br J Dermatol 2000; 143: 356-9
52. Loo WJ, Lanigan SW. Recent advances in laser therapy for the treatment of cutaneous vascular disorders. Lasers Med Sci 2002; 17: 9-12
53. Poetke M, Philipp C, Berlien HP. Flashlamp-pumped pulsed dye laser for hemangiomas in infancy: treatment of superficial vs mixed hemangiomas. Arch Dermatol 2000; 136: 628-32
54. Batta K, Goodyear HM, Moss C, et al. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis. Lancet 2002; 360: 521-7
55. Scherer K, Lorenz S, Wimmershoff M, et al. Both the flashlamp-pumped dye laser and the long-pulsed tunable dye laser can improve results in port-wine stain therapy. Br J Dermatol 2001; 145: 79-84
56. Raulin C, Greve B. Retrospective clinical comparison of hemangioma treatment by flashlamp-pumped (585 nm) and frequency-doubled Nd: YAG (532 nm) lasers. Lasers Surg Med 2001; 28: 40-3
57. Werner JA, Dünne AA, Folz BJ, et al. Current concepts in the classification, diagnosis and treatment of hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol 2001; 258: 141-9
58. Mathewson R, Coleridge-Smith P, O'Sullivan J, et al. Biological effects of intrahepatic neodymium:yttrium-aluminium-garnet laser photocoagulation in rats. Gastroenterology 1987; 93: 550-7
59. Demiri EC, Pelissier P, Genin-Etcheberry T, et al. Treatment of facial haemangiomas: the present status of surgery. Br J Plast Surg 2001; 54: 665-74
60. Jain R, Bandhu S, Sawhney S, et al. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations. J Clin Ultrasound 2002; 30: 416-23
61. Puig S, Aref H, Chigot V, et al. Classification of venous malformations in children and implications for sclerotherapy. Pediatr Radiol 2003; 33: 99-103
62. Winter H, Drager E, Sterry W. Sclerotherapy for treatment of hemangiomas. Dermatol Surg 2000; 26: 105-8
63. Baud AV, Breton P, Guibaud L, et al. Treatment of low-pressure vascular malformations by injection of Ethibloc: study of 19 cases and analysis of complications. Rev Stomatol Chir Maxillofac 2000; 101: 181-8
64. Luzzatto C, Midrio P, Tchaprassian Z, et al. Sclerosing treatment of lymphangiomas with OK-432. Arch Dis Child 2000; 82: 316-8
65. Samuel M, McCarthy L, Boddy SA. Efficacy and safety of OK-432 sclerotherapy for giant cystic hygroma in a newborn. Fetal Diagn Ther 2000; 15: 93-6
66. DA Loose, J Weber, editors. Angeborene gefäßmiß bildungen: interdisziplinäre diagnostik und therapie von hämangiomen und gefäßmalformationen. Lüneburg: Periodica Angiologica, Nordlanddruck, 1997
67. Stanley RJ, Cubillo E. Nonsurgical treatment of arteriovenous malformations of the trunk and limbs by transcatheter embolization. Radiology 1975; 115: 609-12